APA-Zitierstil (7. Ausg.)

Marisi, G., & Raimondi, F. (2019). ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib. Cancers, 11(7), . https://doi.org/10.3390/cancers11071023

Chicago-Zitierstil (17. Ausg.)

Marisi, Giorgia, und Francesco Raimondi. "ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib." Cancers 11, no. 7 (2019). https://doi.org/10.3390/cancers11071023.

MLA-Zitierstil (9. Ausg.)

Marisi, Giorgia, und Francesco Raimondi. "ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib." Cancers, vol. 11, no. 7, 2019, https://doi.org/10.3390/cancers11071023.